SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

21 Oct 2014 07:00

RNS Number : 8018U
Devro PLC
21 October 2014
 



For immediate release 21 October 2014

 

 

Devro plc

(the "Group")

 

Interim Management Statement

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 July 2014 to date.

Trading has continued in line with expectations. The business now has had two quarters of growing sales volumes year on year, most notably in China, Japan and Germany, with demand generally showing signs of improvement. Inventory is reducing as expected.

The major investment projects in China and the USA are both proceeding to plan. The replacement of our existing facility in South Carolina addresses the older plant's continued underperformance; an eighteen month programme of transition to the new manufacturing operations has now commenced. Net debt to fund the two projects is rising in line with our expectations. The first phase of the restructuring of our operations in Scotland has been completed on schedule in August and the second phase will conclude at the end of Q1 2015.

The outlook for the full year remains unchanged.

 

ENDS

 

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Sophie McNulty/

Clare Akhurst

 

 

 

Tel No: 020 7466 5000

 

Notes to Editors

 

FTSE listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £242.7 million and profit before tax (before exceptional items) of £38.8 million for the year ended 31 December 2013. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMZGKGVGDZM
Date   Source Headline
7th Apr 20204:00 pmRNS2019 Annual Report and Notice of AGM
31st Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSDirectorate Changes
9th Mar 20202:26 pmRNSHolding(s) in Company
6th Mar 20205:10 pmRNSDirector/PDMR Shareholding
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSFull Year Results
17th Jan 20207:00 amRNSTrading Update
12th Dec 20198:42 amRNSDirector Declaration
25th Oct 20195:31 pmRNSDirector/PDMR Shareholding
24th Oct 201910:57 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSTrading Update & Manufacturing Footprint Review
10th Oct 201911:44 amRNSDirector/PDMR Shareholding
20th Sep 201912:59 pmRNSHolding(s) in Company
14th Aug 20191:45 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSHALF YEAR RESULTS
5th Jul 20191:17 pmRNSHolding(s) in Company
19th Jun 20197:00 amRNSHolding(s) in Company
15th May 20196:24 pmRNSDirector/PDMR Shareholding
14th May 20193:44 pmRNSDirector/PDMR Shareholding
7th May 20197:00 amRNSDirectorate Changes
2nd May 20193:28 pmRNSDirector/PDMR Shareholding
25th Apr 20194:04 pmRNSResult of AGM
25th Apr 20197:00 amRNSTrading Update
12th Apr 20191:08 pmRNSCompany Secretary change
11th Apr 201910:48 amRNSDirector/PDMR Shareholding
22nd Mar 20194:07 pmRNS2018 Annual Report and Notice of AGM
19th Mar 20192:00 pmRNSCapital Markets Event
6th Mar 20192:09 pmRNSDirector/PDMR Shareholding
6th Mar 20192:08 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFull Year Results
20th Feb 20193:27 pmRNSHolding(s) in Company
14th Feb 201911:59 amRNSHolding(s) in Company
14th Feb 201911:34 amRNSDirector/PDMR Shareholding
23rd Jan 20193:02 pmRNSHolding(s) in Company
10th Dec 20184:05 pmRNSHolding(s) in Company
4th Dec 20184:46 pmRNSHolding(s) in Company
20th Nov 20183:33 pmRNSHolding(s) in Company
20th Nov 201811:51 amRNSHolding(s) in Company
19th Nov 20181:35 pmRNSDirector/PDMR Shareholding
19th Nov 20181:34 pmRNSDirector/PDMR Shareholding
16th Nov 201810:33 amRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSRetirement of Chairman
15th Nov 20187:00 amRNSTrading Update
5th Nov 20181:49 pmRNSHolding(s) in Company
23rd Oct 20183:47 pmRNSHolding(s) in Company
15th Oct 20184:27 pmRNSDirector/PDMR Shareholding
18th Sep 201811:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.